The annual membership costs $499, and includes testing for 100+ biomarkers related to heart health, metabolic function, inflammation, liver and kidney function, hormones, nutrient levels, and more.

In the final clip, James D. Chalmers, MBChB, PhD, notes that while the FDA approval of brensocatib is a milestone, questions remain on optimal patient selection, long-term benefits, and further ...